JNJ-38224342
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JNJ-38224342, covering 2013-09-04 to 2013-09-04. Get the full timeline:
Most recent: Clinical Trial Update: A Single and Multiple Dose Study to Explore the Safety of JNJ-38224342 in Healthy Patients and Patients With Seasonal Allergies [Phase 1]